bucladesine and Mouth Neoplasms

bucladesine has been researched along with Mouth Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Basu, S; Dasgupta, PS; Majumder, J; Mondal, AC; Saha, B	1

Other Studies

1 other study(ies) available for bucladesine and Mouth Neoplasms

Article	Year
Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism. Neuroimmunomodulation, 2001, Volume: 9, Issue:1 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Adenylyl Cyclase Inhibitors; Adult; Bucladesine; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Division; Cells, Cultured; Cyclic AMP; Cytotoxicity, Immunologic; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-2; Lymphocyte Activation; Male; Middle Aged; Mouth Neoplasms; Neuroimmunomodulation; Psychoneuroimmunology; Receptors, Dopamine; Second Messenger Systems; Stress, Psychological; Theophylline	2001

Article

Year

Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism.

Neuroimmunomodulation, 2001, Volume: 9, Issue:1

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Adenylyl Cyclase Inhibitors; Adult; Bucladesine; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Division; Cells, Cultured; Cyclic AMP; Cytotoxicity, Immunologic; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-2; Lymphocyte Activation; Male; Middle Aged; Mouth Neoplasms; Neuroimmunomodulation; Psychoneuroimmunology; Receptors, Dopamine; Second Messenger Systems; Stress, Psychological; Theophylline

2001